Cargando…
Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison
INTRODUCTION: Since older patients with breast cancer are underrepresented in clinical trials, an oncogeriatric approach is advocated to guide treatment decisions. However, the effect on outcomes is unclear. The aim of this study was to compare treatments and outcomes between patients treated in an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599178/ https://www.ncbi.nlm.nih.gov/pubmed/32813120 http://dx.doi.org/10.1007/s10549-020-05860-7 |
_version_ | 1783602815538561024 |
---|---|
author | de Boer, Anna Z. van de Water, Willemien Bastiaannet, Esther de Glas, Nienke A. Kiderlen, Mandy Portielje, Johanneke E. A. Extermann, Martine |
author_facet | de Boer, Anna Z. van de Water, Willemien Bastiaannet, Esther de Glas, Nienke A. Kiderlen, Mandy Portielje, Johanneke E. A. Extermann, Martine |
author_sort | de Boer, Anna Z. |
collection | PubMed |
description | INTRODUCTION: Since older patients with breast cancer are underrepresented in clinical trials, an oncogeriatric approach is advocated to guide treatment decisions. However, the effect on outcomes is unclear. The aim of this study was to compare treatments and outcomes between patients treated in an oncogeriatric and a standard care setting. METHODS: Patients aged ≥ 70 years with early stage breast cancer were included. The oncogeriatric cohort comprised unselected patients from the Moffitt Cancer Center, and the standard cohort patients from a Dutch population-based cohort. Cox models were used to characterize the influence of care setting on recurrence risk and overall mortality. RESULTS: Overall, 268 patients were included in the oncogeriatric and 1932 patients in the standard cohort. Patients in the oncogeriatric cohort were slightly younger, had more comorbidity, and received more adjuvant endocrine therapy and chemotherapy. Oncogeriatric care was associated with a lower risk of recurrence, which remained significant after adjustment for patient and tumour characteristics [hazard ratio (HR) 0.66, 95% confidence interval (CI) 0.44–0.99]. Oncogeriatric care was also associated with a lower overall mortality, which also remained significant after adjustment for patient and tumour characteristics (HR 0.69, 95% CI 0.55–0.87). CONCLUSIONS: Patients treated in the oncogeriatric care setting had a lower risk of recurrence, which may be explained by more systemic treatment. Overall mortality was also lower, but other explanations besides care setting could not be ruled out as the cohorts had different patient profiles. Future studies need to clarify the impact of an oncogeriatric approach on outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-020-05860-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7599178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-75991782020-11-10 Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison de Boer, Anna Z. van de Water, Willemien Bastiaannet, Esther de Glas, Nienke A. Kiderlen, Mandy Portielje, Johanneke E. A. Extermann, Martine Breast Cancer Res Treat Epidemiology INTRODUCTION: Since older patients with breast cancer are underrepresented in clinical trials, an oncogeriatric approach is advocated to guide treatment decisions. However, the effect on outcomes is unclear. The aim of this study was to compare treatments and outcomes between patients treated in an oncogeriatric and a standard care setting. METHODS: Patients aged ≥ 70 years with early stage breast cancer were included. The oncogeriatric cohort comprised unselected patients from the Moffitt Cancer Center, and the standard cohort patients from a Dutch population-based cohort. Cox models were used to characterize the influence of care setting on recurrence risk and overall mortality. RESULTS: Overall, 268 patients were included in the oncogeriatric and 1932 patients in the standard cohort. Patients in the oncogeriatric cohort were slightly younger, had more comorbidity, and received more adjuvant endocrine therapy and chemotherapy. Oncogeriatric care was associated with a lower risk of recurrence, which remained significant after adjustment for patient and tumour characteristics [hazard ratio (HR) 0.66, 95% confidence interval (CI) 0.44–0.99]. Oncogeriatric care was also associated with a lower overall mortality, which also remained significant after adjustment for patient and tumour characteristics (HR 0.69, 95% CI 0.55–0.87). CONCLUSIONS: Patients treated in the oncogeriatric care setting had a lower risk of recurrence, which may be explained by more systemic treatment. Overall mortality was also lower, but other explanations besides care setting could not be ruled out as the cohorts had different patient profiles. Future studies need to clarify the impact of an oncogeriatric approach on outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-020-05860-7) contains supplementary material, which is available to authorized users. Springer US 2020-08-19 2020 /pmc/articles/PMC7599178/ /pubmed/32813120 http://dx.doi.org/10.1007/s10549-020-05860-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Epidemiology de Boer, Anna Z. van de Water, Willemien Bastiaannet, Esther de Glas, Nienke A. Kiderlen, Mandy Portielje, Johanneke E. A. Extermann, Martine Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison |
title | Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison |
title_full | Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison |
title_fullStr | Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison |
title_full_unstemmed | Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison |
title_short | Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison |
title_sort | early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599178/ https://www.ncbi.nlm.nih.gov/pubmed/32813120 http://dx.doi.org/10.1007/s10549-020-05860-7 |
work_keys_str_mv | AT deboerannaz earlystagebreastcancertreatmentandoutcomeofolderpatientstreatedinanoncogeriatriccareandastandardcaresettinganinternationalcomparison AT vandewaterwillemien earlystagebreastcancertreatmentandoutcomeofolderpatientstreatedinanoncogeriatriccareandastandardcaresettinganinternationalcomparison AT bastiaannetesther earlystagebreastcancertreatmentandoutcomeofolderpatientstreatedinanoncogeriatriccareandastandardcaresettinganinternationalcomparison AT deglasnienkea earlystagebreastcancertreatmentandoutcomeofolderpatientstreatedinanoncogeriatriccareandastandardcaresettinganinternationalcomparison AT kiderlenmandy earlystagebreastcancertreatmentandoutcomeofolderpatientstreatedinanoncogeriatriccareandastandardcaresettinganinternationalcomparison AT portieljejohannekeea earlystagebreastcancertreatmentandoutcomeofolderpatientstreatedinanoncogeriatriccareandastandardcaresettinganinternationalcomparison AT extermannmartine earlystagebreastcancertreatmentandoutcomeofolderpatientstreatedinanoncogeriatriccareandastandardcaresettinganinternationalcomparison |